Omalizumab Rescue Therapy for Refractory Status Asthmaticus

Ann Intern Med. 2019 Mar 5;170(5):351-352. doi: 10.7326/L18-0359. Epub 2018 Nov 20.

Authors

Katrin Milger¹, Ines Schroeder², Jürgen Behr¹, Tobias Meis³, Werner V Wulffen³, Nikolaus Kneidinger¹

Affiliations

¹ Ludwig-Maximilians-University of Munich and Comprehensive Pneumology Center, Munich, Germany (K.M., J.B., N.K.).
² Ludwig-Maximilians-University of Munich, Munich, Germany (I.S.).
³ Klinik Augustinum München, Munich, Germany (T.M., W.V.W.).

PMID: 30458534
DOI: 10.7326/L18-0359

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Asthmatic Agents / administration & dosage
Dose-Response Relationship, Drug
Humans
Injections, Subcutaneous
Male
Omalizumab / administration & dosage*
Respiration, Artificial
Status Asthmaticus / therapy*
Treatment Outcome

Substances

Anti-Asthmatic Agents
Omalizumab